Talquetamab and teclistamab combination improved response in relapsed multiple myeloma
1. In this randomized controlled trial, in patients with relapsed or refractory multiple myeloma (MM), combination therapy of talquetamab and ...
Tag: teclistamab
Biologic teclistamab shows promise in treatment of refractory multiple myeloma in phase 1 drug study
1. Patients on the recommended phase 2 dosage of teclistamab had no dose-limiting adverse events. 2. There was a 65% ...